Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
A Roivant Sciences spinout says it has made the first AI model, to its knowledge, that simultaneously predicts biomolecule structures while generating new molecules. …
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The FDA on Thursday approved Alnylam’s Amvuttra for a rare heart disease, giving the company an expected yet significant win. Amvuttra is now approved to
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Shenyang Institute of Computing Technology, CAS and Chinese PLA General Hospital Joint Team conduct series of investigations on Infantile Spasms Syndrome (IESS), also known as
Tuberculosis (TB) continued to rise again in the U.S. last year, reaching its highest levels in more than a dozen years. More than 10,300 cases
Every spring, thousands of medical students across the country discover where they’ll begin their residency — and their careers as physicians. It’s called Match Day,